Retinitis Pigmentosa Rp clinical trials

Explore recruiting retinitis pigmentosa rp clinical trials.

Recruiting retinitis pigmentosa rp studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Retinitis Pigmentosa Rp trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) due to Mutations in Exon 13 of the USH2A Gene

France, Belgium, Netherlands, Germany, Denmark, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) due to Mutations in Exon 13 of the USH2A Gene

Netherlands, Germany, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Retinitis Pigmentosa Rp trials by city

Retinitis Pigmentosa Rp clinical trials

Recruiting retinitis pigmentosa rp studies right now

Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa

Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration

Stem Cell Ophthalmology Treatment Study II

Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital

COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Monocentric Interventional Study

Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration

High Resolution, High-speed Multimodal Ophthalmic Imaging

A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa

Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity

Also recruiting in Europe

A Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) due to Mutations in Exon 13 of the USH2A Gene

A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) due to Mutations in Exon 13 of the USH2A Gene

Retinitis Pigmentosa Rp trials by city

Other conditions